Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 20:29 | 3/26/24 | TSVT | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | D | P | 204 | 5.10 | 0 | 40 | 2 | 2,017 | I | |||||||||||||||
3/25/24 21:44 | 3/21/24 | TSVT | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | D | P.dm | 3,899 | 5.02 | 0 | 777 | 65 | 1,977 | I | |||||||||||||||
8/16/23 19:11 | 8/10/23 | TSVT | Health | Drug | Pharmaceutical Preparations | Kynam Global Healthcare Master Fund, LP | E9 | T | P | 3,564 | 5.92 | 0 | 602 | 6 | 10,284 | M | |||||||||||||||
8/14/23 20:51 | 8/10/23 | TSVT | Health | Drug | Pharmaceutical Preparations | Kynam Capital Management, LP | NJ | T | P | 3,564 | 5.92 | 0 | 602 | 6 | 10,284 | M | |||||||||||||||
3/22/22 16:55 | 3/17/22 | TSVT | Health | Drug | Pharmaceutical Preparations | Leschly Nick | MA | DO | P,CEO | P.a | 4,500 | 12.20 | 0 | 369 | 196 | 557 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |